Marina Rautenbach

Title: Innovations of Marina Rautenbach

Introduction

Marina Rautenbach is a notable inventor based in Stellenbosch, South Africa. She has made significant contributions to the field of microbial growth prevention and malaria treatment through her innovative patents. With a total of 2 patents, her work reflects a commitment to advancing medical and health-related technologies.

Latest Patents

One of her latest patents is a method for preventing or treating microbial growth on manufactured products. This invention provides a composition comprising a cyclic decapeptide, which can be applied to various products, including medical devices, wound dressings, and food packaging. The cyclic decapeptides are designed to adsorb onto the product, effectively disinfecting or sterilizing surfaces and inhibiting biofilm formation.

Another significant patent is a peptide-polymer conjugate aimed at treating malaria infections, particularly drug-resistant strains. This conjugate combines a hydrophilic and biocompatible polymer with a cyclic decapeptide that targets malaria parasites. The innovative design includes a targeting ligand that specifically binds to infected red blood cells, enhancing the effectiveness of the treatment.

Career Highlights

Marina Rautenbach is affiliated with Stellenbosch University, where she conducts her research and develops her inventions. Her work has garnered attention for its potential impact on public health and safety.

Collaborations

Some of her notable coworkers include Wilma Van Rensburg and Lubertus Klumperman, who contribute to her research efforts and innovations.

Conclusion

Marina Rautenbach's contributions to the fields of microbial growth prevention and malaria treatment highlight her role as a leading inventor. Her innovative patents demonstrate a dedication to improving health outcomes through scientific advancements.